All 51 GNOM (GLOBAL X GENOMICS & BIOTECHNOLOGY ETF) Holdings
There are 51 GNOM holdings. Top 10 companies weight: 44.50%.
Total Market Cap: $2.20T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (51 stocks) | +24.58% | 32.26 | 22.10 | 0.29 | +16.83% | +20.83% | 0.66 | ||||||||||
1 | GH | Guardant Health Inc | 6.34% | $148.07 | $21B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 77 | +15.54% | $171 | +4.43% | 1.17 |
2 | TWST | Twist Bioscience Corp | 5.22% | $87.45 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | +1.20% | $89 | -6.60% | 2.02 |
3 | ILMN | Illumina Inc | 4.68% | $184.68 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -9.23% | $168 | -16.96% | 1.00 |
4 | NTRA | Natera Inc | 4.42% | $262.63 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +7.43% | $282 | +17.53% | 1.29 |
5 | MRNA | Moderna Inc | 4.33% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
6 | VCYT | Veracyte Inc | 4.04% | $57.26 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -1.24% | $57 | +8.04% | 1.36 |
7 | TECH | Bio-techne Corp | 4.03% | $71.64 | $11B | Biotechnology | Healthcare | -10.07% | 101.96 | 34.48 | 0.96 | N/A | N/A | 58 | -2.29% | $70 | -8.73% | 1.13 |
8 | TXG | 10x Genomics Inc Ordinary Shares Class A | 3.83% | $43.22 | $5.87B | Health Information Services | Healthcare | N/A | N/A | 714.29 | N/A | N/A | N/A | 60 | -7.80% | $40 | -25.16% | 2.04 |
9 | LEGN | Legend Biotech Corp Adr | 3.83% | $23.21 | $4.26B | Biotechnology | Healthcare | -13.49% | N/A | 149.25 | N/A | N/A | N/A | 80 | +139.68% | $56 | -13.38% | 0.49 |
10 | VRTX | Vertex Pharmaceuticals Inc | 3.78% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
11 | ARWR | Arrowhead Pharmaceuticals Inc | 3.62% | $71.65 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +33.98% | $96 | +1.03% | 1.63 |
12 | BMRN | Biomarin Pharmaceutical Inc | 3.55% | $59.11 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.81% | $88 | -5.79% | 0.65 |
13 | CRSP | Crispr Therapeutics Ag | 3.28% | $46.99 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +83.46% | $86 | -18.22% | 1.44 |
14 | QGEN | Qiagen Nv | 3.25% | $40.48 | $8.51B | Diagnostics & Research | Healthcare | +3.15% | 20.03 | 12.94 | 0.05 | N/A | N/A | 70 | +8.87% | $44 | -4.19% | 0.50 |
15 | PRAX | Praxis Precision Medicines Inc Ordinary Shares | 3.15% | $304.43 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +100.39% | $610 | +3.11% | 0.93 |
16 | BNTX | Biontech Se Adr | 2.87% | $92.16 | $23B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 70 | +32.63% | $122 | -18.34% | 0.94 |
17 | BEAM | Beam Therapeutics Inc | 2.70% | $26.33 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +98.67% | $52 | -23.20% | 1.82 |
18 | RARE | Ultragenyx Pharmaceutical Inc | 2.62% | $28.53 | $3.12B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +84.12% | $53 | -19.60% | 0.97 |
19 | QURE | Uniqure Nv | 2.17% | $39.70 | $2.58B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 75 | +63.40% | $65 | +7.92% | 0.98 |
20 | LLY | Eli Lilly And Co | 2.13% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
21 | BLLN | Billiontoone Inc Ordinary Shares Class A | 2.10% | $125.14 | $5.97B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | -2.40% | $122 | 0.00% | 1.77 |
22 | CAI | Caris Life Sciences Inc | 1.96% | $15.56 | $4.94B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 71 | +73.52% | $27 | 0.00% | 1.42 |
23 | NTLA | Intellia Therapeutics Inc | 1.68% | $10.92 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +139.65% | $26 | -41.00% | 1.77 |
24 | WGS | Genedx Holdings Corp Ordinary Shares Class A | 1.60% | $60.65 | $1.96B | Diagnostics & Research | Healthcare | N/A | N/A | 204.08 | N/A | N/A | N/A | 77 | +34.84% | $82 | -31.83% | 1.65 |
25 | SRPT | Sarepta Therapeutics Inc | 1.58% | $16.83 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.01 | 159.25 | N/A | N/A | 48 | +31.73% | $22 | -24.47% | 1.40 |
26 | GILD | Gilead Sciences Inc | 1.57% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
27 | AZN | Astrazeneca Plc | 1.56% | $164.40 | $296B | Drug Manufacturers - General | Healthcare | +17.09% | 28.44 | 16.39 | 0.84 | N/A | N/A | 77 | +30.10% | $214 | +9.82% | 0.36 |
28 | n/a | Genscript Biotech Corp Class H | 1.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
29 | STOK | Stoke Therapeutics Inc | 1.32% | $27.68 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +65.53% | $46 | -3.27% | 1.04 |
30 | CDNA | Caredx Inc | 1.16% | $38.37 | $1.53B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | -14.00% | $33 | -14.62% | 1.27 |
31 | DHR | Danaher Corp | 1.07% | $201.52 | $142B | Diagnostics & Research | Healthcare | -4.86% | 38.55 | 24.10 | 1.28 | N/A | N/A | 75 | +20.35% | $243 | -3.53% | 0.79 |
32 | BMY | Bristol-myers Squibb Co | 0.98% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
33 | VIR | Vir Biotechnology Inc | 0.96% | $9.23 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +133.59% | $22 | -24.33% | 1.52 |
34 | PSNL | Personalis Inc | 0.82% | $13.34 | $1.65B | Diagnostics & Research | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 75 | -0.37% | $13 | -10.06% | 2.30 |
35 | WVE | Wave Life Sciences Ltd | 0.79% | $5.73 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +282.90% | $22 | -3.51% | 1.46 |
36 | MRVI | Maravai Lifesciences Holdings Inc Ordinary Shares Class A | 0.56% | $6.99 | $451M | Biotechnology | Healthcare | N/A | N/A | 370.37 | N/A | N/A | N/A | 65 | -15.59% | $5.90 | -29.72% | 1.21 |
37 | RGNX | Regenxbio Inc | 0.53% | $10.32 | $633M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +135.17% | $24 | -22.82% | 1.83 |
38 | MYGN | Myriad Genetics Inc | 0.46% | $5.92 | $596M | Diagnostics & Research | Healthcare | N/A | N/A | 54.05 | N/A | N/A | N/A | 50 | +5.57% | $6.25 | -28.67% | 1.06 |
39 | PACB | Pacific Biosciences Of California Inc | 0.41% | $1.36 | $475M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 57 | +80.74% | $2.46 | -46.62% | 1.95 |
40 | BRKR | Bruker Corp | 0.38% | $56.17 | $8.93B | Medical Devices | Healthcare | N/A | N/A | 15.22 | 1.52 | N/A | N/A | 67 | +6.37% | $60 | -6.55% | 1.23 |
41 | BNTC | Benitec Biopharma Inc | 0.36% | $11.97 | $447M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +115.54% | $26 | -28.81% | 0.76 |
42 | FLGT | Fulgent Genetics Inc | 0.36% | $19.61 | $606M | Diagnostics & Research | Healthcare | N/A | N/A | 7.70 | N/A | N/A | N/A | 62 | -5.66% | $19 | -25.27% | 0.66 |
43 | A | Agilent Technologies Inc | 0.32% | $130.27 | $38B | Diagnostics & Research | Healthcare | +10.55% | 26.96 | 19.57 | 1.20 | N/A | N/A | 77 | +22.30% | $159 | -1.95% | 0.96 |
44 | PRME | Prime Medicine Inc | 0.32% | $3.05 | $630M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +133.44% | $7.12 | 0.00% | 2.09 |
45 | RCKT | Rocket Pharmaceuticals Inc | 0.31% | $3.43 | $398M | Biotechnology | Healthcare | -5.96% | N/A | N/A | N/A | N/A | N/A | 53 | +173.76% | $9.39 | -40.75% | 1.35 |
46 | EDIT | Editas Medicine Inc | 0.28% | $2.88 | $349M | Biotechnology | Healthcare | -10.67% | N/A | N/A | N/A | N/A | N/A | 55 | +100.69% | $5.78 | -42.06% | 2.15 |
47 | MLAB | Mesa Laboratories Inc | 0.26% | $96.67 | $523M | Scientific & Technical Instruments | Technology | N/A | 77.63 | 35.21 | N/A | N/A | N/A | N/A | +15.86% | $112 | -18.92% | 1.48 |
48 | DGX | Quest Diagnostics Inc | 0.26% | $207.69 | $22B | Diagnostics & Research | Healthcare | +8.13% | 22.47 | 19.61 | 1.54 | N/A | N/A | 62 | +7.82% | $224 | +11.01% | 0.17 |
49 | n/a | Cash | 0.24% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
50 | LAB | Standard Biotools Inc | 0.23% | $0.85 | $328M | Medical Devices | Healthcare | N/A | 4.26 | N/A | N/A | N/A | N/A | 62 | +82.35% | $1.55 | -25.92% | 1.56 |
GNOM (GLOBAL X GENOMICS & BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
90.40%MATERIALS
1.60%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%